NeOnc Technologies Holdings GAAP EPS of $0.30

* NeOnc Technologies Holdings press release [https://seekingalpha.com/pr/20205072-neonc-technologies-holdings-reports-second-quarter-2025-results-and-provides-operational] (NASDAQ:NTHI [https://seekingalpha.com/symbol/NTHI]): Q2 GAAP EPS of $0.30.
* G&A expenses: $984K vs. $290K in Q2 2024, reflecting expanded marketing, rent, travel, and Middle East partnership-related costs.
* R&D expenses: $677K vs. $394K in Q2 2024, driven by additional NEO100 trial sites, increased recruitment for NEO212, initiation of NEO100-3, and overall patient recruitment expansion.

MORE ON NEONC TECHNOLOGIES HOLDINGS

* NeOnc Technologies signs agreement for $50M partnership with Quazar Investment [https://seekingalpha.com/news/4473326-neonc-technologies-signs-agreement-for-50m-partnership-with-quazar-investment]
* Financial information for NeOnc Technologies Holdings [https://seekingalpha.com/symbol/NTHI/income-statement]